Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody

BACKGROUND: Hepatitis C virus antibody (anti‐HCV) test had been approved as a preliminary screening test for HCV infection. Light‐initiated chemiluminescent assay (LiCA) was a homogenous method. We aimed to assess the clinical diagnostic performance of LiCA and compare it with that of chemiluminesce...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shuo, Yang, Ruifeng, Zhang, Siyu, Liu, Di, Zhou, Jiansuo, Wang, Tiancheng, Cui, Liyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757125/
https://www.ncbi.nlm.nih.gov/pubmed/31148296
http://dx.doi.org/10.1002/jcla.22928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757125/
https://www.ncbi.nlm.nih.gov/pubmed/31148296
http://dx.doi.org/10.1002/jcla.22928

Ejemplares similares